Approvals/NMPA/Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approved

生物制品

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

礼来苏州制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 8VFqusO7bgC
Approval Number: 国药准字S20237011
Generic Name: 精蛋白锌重组赖脯胰岛素混合注射液(25R)
Generic Name En: Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)
Trade Name: 优泌乐25
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位（笔芯）
Reg Date: 2023-11-03
Company Name: 礼来苏州制药有限公司
Company Address: 苏州工业园区方中街109号
Production Company Name: 礼来苏州制药有限公司
Production Company Address: 苏州工业园区方中街109号
Company Detail Path: /organization/li-lai-su-zhou-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/li-lai-su-zhou-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 3, 2023

Approval ID

8VFqusO7bgC

Type

生物制品